Investors 2019
AbbVie

 
Abingworth
Advent Life Sciences
Akesios Associates
Alacrita
Albion Capital
ALSA Holdings
Angel CoFund
Arix Bioscience
Arlington Group
Arrowfield Capital
Astrocyte Consulting

 
BioCity
BioScience Managers
Cambridge Innovation Capital
Clubb Capital
Covance
DN Capital
Downing
EA Pharma Co
Envestors
Epidarex Capital
Equity Strategies
e-Therapeutics
F-Prime Capital
Front Seat Capital
Globe Life Sciences
Glory Global Solutions
Graffiti Syndicate
i&i Prague
IDBS
Ignite Capital Partners
Image Analysis Group
IP Group
J&J Innovation
Kurma Partners
Life Science Partners
LifeArc
Lilly
Longacre Partnerships
MedImmune
Meltwind
Mercia Technologies
Midven
MSD
Neural Insights
New Mosaic
New Wave Ventures
New Star Ventures
Norgine Ventures
o2h Ventures
Octopus Investments
Optum Ventures
Oxford Technology
Oxford University Innovation
Queen Mary Innovation
Sanofi
Scottish Development Int
Seroba Life Sciences
Simon Bennett Associates
Social Impact Capital
Sygnature Discovery
SyndicateRoom
UCB Ventures
UMIP
Velocity Fund Partners
Wren Capital
Venue   Contact    

Level39
One Canada Square
Canary Wharf
London E14 5AB


 
 
General Enquiries
E: sarah.walker
@obn.org.uk
T: +44 (0)1235 420870


 
   
Processing. Please wait.
Loading...